Development and validation of a novel clinical fluorescence in situ hybridization assay to detect JAK2 and PD-L1 amplification: a fluorescence in situ hybridization assay for JAK2 and PD-L1 amplification

Meixuan Chen,Mariacarla Andreozzi,Barbara A. Pockaj,Michael T. Barrett,Idris T. Ocal,Ann E. McCullough,Maria E. Linnaus,James M. Chang,Jennifer H. Yearley,Lakshmanan Annamalai,Karen S. Anderson

Development and validation of a novel clinical fluorescence in situ hybridization assay to detect JAK2 and PD-L1 amplification: a fluorescence in situ hybridization assay for JAK2 and PD-L1 amplification

2017

Meixuan Chen
Mariacarla Andreozzi
Barbara A. Pockaj
Michael T. Barrett
Idris T. Ocal
Ann E. McCullough
Maria E. Linnaus
James M. Chang
Jennifer H. Yearley
Lakshmanan Annamalai
Karen S. Anderson

Development and validation of a novel clinical fluorescence in situ hybridization assay to detect JAK2 and PD-L1 amplification: a fluorescence in situ hybridization assay for JAK2 and PD-L1 amplification

Keywords:

Cancer research
Biology
Molecular biology
Fluorescence in situ hybridization
Cancer
Immunohistochemistry
Chromosome 9
Comparative genomic hybridization
Triple-negative breast cancer
Chromosome
Centromere

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations